FDA set potential fiscal year 2022 fees for import reinspections, domestic and foreign facility reinspections, and recall activities the agency performs if a firm fails to comply with a mandatory recall order, though it still isn't invoicing for services associated with the fees, it said in a notice released July 27. The agency set FY22 fees of $277 per hour for domestic services involving travel and $330 hourly if foreign travel is required.
On July 23 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA is working with CBP to conduct a pilot on the use of blockchain and cloud technologies to trace food supply chains “from farm to importation,” said Dawne Hines, director of the FDA Division of Northeast Imports, July 22 during CBP’s Virtual Trade Week. The proof of concept aims to aid “government to government communications,” reduce data duplication and move toward the future elimination of paper, she said.
On July 22 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA has issued its weekly Enforcement Report for July 21, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
On July 21 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 20 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 19 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 15 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 14 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of: